What is Sepsis?
Sepsis is the body’s extreme response to an infection. It is a life-threatening organ dysfunction caused by a dysregulated host response to an infection. Though many people may not be aware of it, sepsis is one of the primary causes of death throughout the world, it is estimated that one in every five deaths worldwide is associated with sepsis.1
Sepsis is a global burden and a major health problem because of its high mortality, morbidity, and high incidence. It affects around 49 million people each year, leading to more than 11 million deaths.2 Sepsis can lead to severe sepsis and septic shock. Approximately 30% of patients diagnosed with severe sepsis do not survive, 3 and up to 50% of survivors suffer from post-sepsis syndrome. It progresses rapidly, and life-saving efforts can have negative impacts on long-term challenges like antimicrobial resistance. In 2017, the World Health Organization (WHO) declared sepsis as a Global Health Priority.4
Learn more about sepsis for healthcare professionals in our Medical Education section.
How does Sepsis occur?
Sepsis can be caused by bacteria, virus, or fungi. There are four types of infections that are most often linked to sepsis: lung infections such as pneumonia, skin infections, gut infections, and urinary tract infections (UTIs). Different types of bacteria can cause these infections, but the most common bacteria associated with sepsis are Escherichia coli, Staphylococcus, and Streptococcus. The most common underlying cause of sepsis-related death is lower respiratory infections causing pneumonia.5
Anyone can get an infection, and almost any infection can lead to sepsis. However, there are some groups of risk who may be more likely to get sepsis, mainly because they are at a higher risk.
The six typical sepsis indicators include:
- Slurred speech or confusion
- Extreme shivering or muscle pain, fever
- Passing no urine all day
- Severe breathlessness
- Extreme pain and discomfort
- Skin mottled or discolored
Since these symptoms are non-specific and can be confused with other conditions, sepsis is often difficult to recognize and diagnose at early stages, when it is still potentially reversible.7
What is the healthcare burden of Sepsis?
As a leading cause of morbidity and mortality with millions of cases a year, sepsis has a substantial economic impact on healthcare systems due to prolonged hospital stays and intensive treatments.
For example, in the United States:
- Sepsis is the #1 cost of hospitalization with an estimated $62 billion annually spent on acute sepsis hospitalization and skilled nursing care.7
- There is a substantial amount of additional costs after discharge for many patients.7
- The average cost per hospital stay for sepsis is double the average cost per stay for all other conditions.7
- Sepsis is the primary cause of readmission to the hospital, costing more than $3.5 billion each year.7
Why should you care about Sepsis?
As is the case in any medical emergency, accurate diagnosis and prompt treatment are critical to ensure the best possible outcomes for patients. Until a cure for sepsis is found, early detection and treatment are essential for survival and to limiting disability caused by sepsis to survivors.7
Initiating and adapting therapy in a timely manner reduces mortality and lowers incidence and severity of long-term symptoms (post-sepsis syndrome).8 It potentially limits unnecessary tests and treatments, shortens hospital stays, and supports antimicrobial stewardship.
In a race against the clock, culture-based diagnosis is not fast enough, and so, in recent years, major efforts have been made to find solutions that allow rapid and accurate diagnosis of this disease. Timely diagnosis is required to adjust treatment, and the delayed results of traditional bacterial cultures and AST remain one of the major barriers to the prompt initiation of appropriate therapy.
Early detection and treatment are absolutely essential to improve both the human and economic impact of sepsis.
Why should you consider Sepsis Solutions from bioMérieux?
Our innovations have positively disrupted conventional sepsis management diagnostics processes providing a much more rapid blood culture, pathogen identification (ID), and antimicrobial susceptibility testing (AST). Rapid diagnostics enables early therapy decision for optimal septic patient management, to support your institution and hospitalization cost savings, preserve the effectiveness of antibiotics, and prevent antimicrobial resistance.
bioMérieux provides the most comprehensive sepsis diagnostics solution in the market offering faster, actionable decision-making information and diagnostics to leverage optimized therapy and patient care for sepsis patients.
We are the partner you can count on for sepsis management. Our solution brings:
- Early therapy decision for optimal septic patient management: Clinicians need diagnostic insights rapidly for timely, appropriate therapy for sepsis. Streamline workflow with the latest diagnostic solutions for rapid identification (ID) and antimicrobial susceptibility testing (AST) directly from positive blood cultures.
- Full integration for increased workflow efficiency and potential hospitalization cost savings: Informed clinical decisions mean improved patient outcomes, with reduced length of therapy and hospital stays. Impact sepsis patient management with rapid and reliable ID & AST solutions that fit your lab workflow and are part of an integrated sepsis solution.
Our Sepsis Solution
Optimize antibiotic therapy for better patient care and enhanced sepsis management in your institution with the bioMérieux Sepsis Solution.
Complete Sepsis Solution by Patient Pathway
SEPSIS Solution
METROMAPS SEPSIS 01
Disclaimer: Product availability varies by country. Please consult your local bioMérieux representative for product availability in your country.
Integrated Offer
Our comprehensive diagnostics solution is backed up by advanced analytics, services, and educational modules to help hospital and laboratories overcome their challenges, reinforced by our promise to be a committed service partner for all our products from consultancy to installation, connectivity, training, verification, and customer service, to help you on optimized time to therapy for better patient care.
bioMérieux
Sepsis Solutions
Useful Resources on Sepsis Solutions
Contact Us
References
1. Zick, Marvin. “The Lancet: Sepsis Associated with 1 in 5 Deaths Worldwide, Double Prior Estimates – Children and Poor Regions Hit Hardest.” Global Sepsis Alliance. Global Sepsis Alliance, January 16, 2020.
2. Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet (London, England). 2020;395(10219):200-11.z
3. Vincent JL, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34:344–353.
4. World Health Organization. WHO Report on the burden of endemic health care-associated infection worldwide. 2017-11-21 15:11:22 2011.
5. Turk J Med Sci. 2021; 51(7): 3301–3311. Published online 2021 Dec 17. doi: 10.3906/sag-2108-239
6. Sepsis Alliance. Sepsis and Long-Term Care. 2022. https://www.sepsis.org/sepsisand/sepsis-long-term-care/
7. Sepsis Alliance. What is Sepsis. 2022. https://www.sepsis.org/sepsis-basics/what-is-sepsis/
8. Evans L, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. PubMed Central, 2021.